CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 3,793.0	$ 3,965.0	$ 3,922.0
Cost of products sold	1,835.0	1,879.0	1,795.0
Gross profit	1,958.0	2,086.0	2,127.0
Selling, general, and administrative expenses	1,605.0	1,613.0	1,589.0
Research and development expenses	165.0	184.0	174.0
Goodwill and intangible asset impairments	1,014.0	307.0	1,287.0
Restructuring costs	53.0	67.0	14.0
Operating loss	(879.0)	(85.0)	(937.0)
Other income and expenses:
Interest expense, net	69.0	81.0	65.0
Other (income) expense, net	(12.0)	9.0	53.0
Loss before income taxes	(936.0)	(175.0)	(1,055.0)
Benefit from income taxes	(26.0)	(43.0)	(105.0)
Net loss	(910.0)	(132.0)	(950.0)
Less: Net income attributable to noncontrolling interests	0.0	0.0	0.0
Net loss attributable to Dentsply Sirona	$ (910.0)	$ (132.0)	$ (950.0)
Net (loss) income per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ (4.48)	$ (0.62)	$ (4.41)
Diluted (in dollars per share)	$ (4.48)	$ (0.62)	$ (4.41)
Weighted average common shares outstanding:
Basic (in shares)	203.2	212.0	215.5
Diluted (in shares)	203.2	212.0	215.5